Position in ZLAB
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,192,493
+$1,031,535 QoQ
Shares Held
116,560
+77.1% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
7 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ZLAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $2,095,517,669 across 139 Biotechnology names. ZLAB ranks #57 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
848,047 | $378,686,906 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
273,120 | $211,023,436 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
885,201 | $167,347,247 | |
| 4 | ARGX |
Argenx SE
|
129,147 | $94,309,595 | |
| 5 | INCY |
Incyte Corp
|
938,848 | $88,364,372 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
1,342,028 | $78,038,926 | |
| 7 | INSM |
INSMED Inc
|
467,753 | $76,486,969 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
907,533 | $68,146,652 |
All Filings in ZLAB
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,192,493 | 116,560 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,160,958 | 65,814 | Shares | Defined | 2026-02-13 | |
| 2022-03-31 | $309,091 | 7,028 | Shares | Defined | 2022-05-12 | |
| 2020-12-31 | $68,223,810 | 504,092 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $6,963,657 | 83,728 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $6,885,697 | 83,839 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $2,225,223 | 43,225 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||